1.
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with poor outcomes, partly due to dysfunctional vascularization and complex tumor-stromal interactions. Th [...]
2025-04-18 | Dissertation |
2.
The overwhelming majority (~90%) of patients with pancreatic ductal adenocarcinoma (PDAC) will be treated with systemic standard-of-care chemotherapeutic regimens at some [...]
2022 | Dissertation |
3.
Proactive mentorship and professional development are fundamental to the success of early career faculty. The Early Career Advancement Program (ECAP) within the OHSU Scho [...]
2025 | Abstract |